首页> 外国专利> Transmucosal administration of drug compositions for treating and preventing disorders in animals

Transmucosal administration of drug compositions for treating and preventing disorders in animals

机译:用于治疗和预防动物疾病的药物组合物的粘膜给药

摘要

#$%^&*AU2013263787B220151105.pdf#####ABSTRACT The invention includes compositions for transmucosal administration to an animal comprising at least one active agent and a pharmaceutically acceptable carrier. A preferred active agent is selected from the group consisting of meloxicam, carprofen, enrofloxacin, clemastine, diphenhydramine, digoxin, levothyroxine, cyclosporine, ondansetron, lysine, zolpidem, propofol, nitenpyram, ivermectin, milbemycin, and pharmaceutically acceptable salts, solvates and esters thereof. In another embodiment, the invention includes methods of treating or preventing a condition in an animal comprising transmucosally administering a composition comprising a therapeutically or prophylactically effective amount of an active agent and a pharmaceutically acceptable carrier.
机译:#$%^&* AU2013263787B220151105.pdf #####抽象本发明包括用于经粘膜施用给动物的组合物,其包含至少一种活性剂和药学上可接受的载体。优选的活性剂是选自美洛昔康,卡洛芬,恩诺沙星,clemastine,苯海拉明,地高辛,左甲状腺素,环孢霉素,恩丹西酮,赖氨酸,唑吡坦,丙泊酚,乙炔菊酯,伊维菌素,米尔贝霉素以及药学上可接受的盐,溶剂化物和酯其。在另一个实施方案中,本发明包括治疗或预防糖尿病的方法。包括经粘膜给药包含治疗或预防有效量的活性剂和药物可接受的载体。

著录项

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号